PT. Clipan Finance Indonesia Tbk (IDX:CFIN)

Verve Therapeutics Cash Flow Statement

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	167,121	214,801	815,005	310,722	46,306	46,567
Depreciation & Amortization	43,735	40,978	34,992	33,142	33,024	33,278
Other Amortization	12,040	8,823	9,233	9,069	9,941	8,445
Other Operating Activities	348,317	-306,445	-1,925,872	-875,481	2,023,622	2,814,938
Operating Cash Flow	571,213	-41,843	-1,066,642	-522,548	2,112,893	2,903,228
Operating Cash Flow Growth	-	-	-	-	-27.22%	-
Capital Expenditures	-11,032	-32,023	-29,959	-28,137	-16,185	-19,231
Sale of Property, Plant & Equipment	8,239	18,400	4,304	3,678	10,401	10,607
Sale (Purchase) of Intangibles	-1,801	-3,421	-4,313	-6,148	-6,439	-3,818
Investing Cash Flow	-4,593	-17,043	-29,967	-30,607	-12,223	-12,442
Long-Term Debt Issued	-	4,553,807	5,614,587	3,087,224	1,270,000	1,895,785
Long-Term Debt Repaid	-	-4,489,977	-4,085,232	-2,629,524	-5,168,674	-2,966,472
Net Debt Issued (Repaid)	-339,804	63,830	1,529,355	457,700	-3,898,674	-1,070,687
Common Dividends Paid	-198,553	-	-398,452	-	-	-
Other Financing Activities	-12,954	-9,884	-32,898	-	-	-
Financing Cash Flow	-551,312	53,946	1,098,005	457,700	-3,898,674	-1,070,687
Foreign Exchange Rate Adjustments	-	-	-	-	-	319.85
Net Cash Flow	15,308	-4,940	1,395	-95,454	-1,798,005	1,820,420
Free Cash Flow	560,181	-73,866	-1,096,600	-550,685	2,096,708	2,883,998
Free Cash Flow Growth	-	-	-	-	-27.30%	-
Free Cash Flow Margin	94.94%	-10.09%	-122.77%	-75.11%	746.14%	670.52%
Free Cash Flow Per Share	140.59	-18.54	-275.21	-138.21	526.21	723.80
Cash Interest Paid	298,031	309,836	234,800	156,015	317,614	567,027
Cash Income Tax Paid	30,603	47,884	236,580	50,653	22,790	41,037

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Financial Services template. Financial Sources.